4180020/2026 - AQ 2023/437 - Antiallergic medication, vitamins and mineral salts and medications used in intoxication

This tender, identified by the reference 4180020/2026 and associated call number AQ 2023/437, pertains to the procurement of specific pharmaceutical products. The items to be acquired include antiallergic medications, vitamins, mineral salts, and medications used for treating intoxication. This indicates a need for a range of treatments addressing allergic reactions, nutritional deficiencies, and poisoning or overdose cases. The contracting authority, likely a healthcare provider, pharmacy, or public health agency, requires these medications to ensure the availability of essential treatments for patients. The reference AQ 2023/437 suggests this might be a call-off from a pre-existing framework agreement or a specific procurement action initiated in 2023 for delivery or service in 2026. The tender will detail the specific types, dosages, quantities, and packaging of the medications required, along with delivery timelines and quality assurance standards. Ensuring a consistent supply of these vital medicines is crucial for public health and patient care, covering a spectrum of common and critical medical needs.

This is a supplies contract in the health and medical services, mining and extractives and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 90.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.